Abstract
Children with dyslipidemia have an increased risk of becoming adults with dyslipidemia who are at risk for premature atherosclerotic cardiovascular disease (CVD) and strokes. In 1992, the National Cholesterol Education Program (NCEP) presented the first guidelines for pediatric lipidology, focusing primarily on low-density lipoprotein cholesterol (LDL-C). Today, the most comprehensive analysis comes from the 2011 National Heart Lung and Blood Institute (NHLBI) Pediatric Guidelines and the 2019 American Heart Association (AHA) updated guidelines. Universal lipid screening is recommended for all children between ages 9 and 11 years and a repeat lipid screen is recommended between 17 and 21 years of age. In addition, all children and adolescents aged 2 years or above who have risk factors/conditions for premature CVD should undergo selective screening.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Hu P, et al. Prevalence of familial hypercholesterolemia among the general population and patients with atherosclerotic cardiovascular disease: a systematic review and meta-analysis. Circulation. 2020;141(22):1742–59.
Gooding HC, et al. Application of pediatric and adult guidelines for treatment of lipid levels among US adolescents transitioning to young adulthood. JAMA Pediatr. 2015;169(6):569–74.
de Ferranti SD, et al. Cardiovascular risk reduction in high-risk pediatric patients: a scientific statement from the American Heart Association. Circulation. 2019;139(13):e603–34.
Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents, National Heart, Lung, and Blood Institute. Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report. Pediatrics. 2011;128(Suppl 5):S213–56.
Bradley CB, et al. Prevalence of high cholesterol, high blood pressure, and smoking among elementary schoolchildren in North Carolina. N C Med J. 1997;58(5):362–7.
Ned RM, Sijbrands EJ. Cascade screening for familial hypercholesterolemia (FH). PLoS Currents. 2011;3:RRN1238.
Cook S, Auinger P, Huang TT. Growth curves for cardio-metabolic risk factors in children and adolescents. J Pediatr. 2009;155(3):S6 e15–26.
American Academy of Pediatrics. National Cholesterol Education Program: report of the expert panel on blood cholesterol levels in children and adolescents. Pediatrics. 1992;89(3 Pt 2):525–84.
Stewart J, et al. Hyperlipidemia. Pediatr Rev. 2020;41(8):393–402.
Shah AS, Wilson DP. Primary hypertriglyceridemia in children and adolescents. J Clin Lipidol. 2015;9(5 Suppl):S20–8.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Foster, C., Sunil, B., Ashraf, A. (2023). Lipid Screening in for Pediatrics. In: Ashraf, A., Sunil, B. (eds) Pediatric Dyslipidemia. Springer, Cham. https://doi.org/10.1007/978-3-031-24113-0_3
Download citation
DOI: https://doi.org/10.1007/978-3-031-24113-0_3
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-24112-3
Online ISBN: 978-3-031-24113-0
eBook Packages: MedicineMedicine (R0)